Trial NCT00791544

View at ClinicalTrials.gov 
Org. Study IDs: TED10630
Secondary IDs: 2008-000809-10

Last trial update was posted on 2010-08-04

MeSH Interventions

Erlotinib Hydrochloride Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Liver Carcinoma

Stopping Reasons

Company decision to discontinue the AVE1642 development program, not due to any safety or efficacy concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID